Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease

Forss, A., Clements, M., Myrelid, P., Strid, H., Söderman, C., Wagner, A., Andersson, D., Hjelm, F., Olén, O., Halfvarson, J., & Ludvigsson, J. F. (2022). Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn’s Disease. Digestive Diseases and Sciences, 68(1), 65–76. https://doi.org/10.1007/s10620-022-07501-z
Authors:
Anders Forss
Mark Clements
Pär Myrelid
Hans Strid
Charlotte Söderman
Agnieszka Wagner
David Andersson
Fredrik Hjelm
Ola Olén
Jonas Halfvarson
Jonas F Ludvigsson
Affiliated Authors:
Jonas F Ludvigsson
Subjects:
Ustekinumab (MeSH)
Crohn Disease (MeSH)
Author Keywords:
crohn's disease
inflammatory bowel disease
observational study
ustekinumab
crohn’s disease
Publication Type:
Article
Unique ID:
10.1007/s10620-022-07501-z
PMID:
Publication Date:
Data Source:
PubMed

Record Created: